O

Ondine Biomedical Inc
LSE:OBI

Watchlist Manager
Ondine Biomedical Inc
LSE:OBI
Watchlist
Price: 8.5 GBX Market Closed
Market Cap: 34.3m GBX
Have any thoughts about
Ondine Biomedical Inc?
Write Note

Operating Margin
Ondine Biomedical Inc

-893.8%
Current
-2 398%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-893.8%
=
Operating Profit
-14.6m
/
Revenue
1.6m

Operating Margin Across Competitors

Country CA
Market Cap 34.9m GBP
Operating Margin
-894%
Country US
Market Cap 199.4B USD
Operating Margin
17%
Country US
Market Cap 190.4B USD
Operating Margin
26%
Country US
Market Cap 139.9B USD
Operating Margin
22%
Country US
Market Cap 133.6B USD
Operating Margin
18%
Country IE
Market Cap 103.6B USD
Operating Margin
19%
Country US
Market Cap 66B USD
Operating Margin
14%
Country DE
Market Cap 58.2B EUR
Operating Margin
12%
Country US
Market Cap 44.6B USD
Operating Margin
28%
Country CN
Market Cap 313.1B CNY
Operating Margin
36%
Country US
Market Cap 36.2B USD
Operating Margin
13%
No Stocks Found

Ondine Biomedical Inc
Glance View

Market Cap
34.3m GBX
Industry
Health Care

Ondine Biomedical, Inc. operates as a life sciences company that develops photodisinfection-based therapies to address drug-resistant infections. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-12-06. The firm is focused on developing products that utilizes its light-activated technology, primarily for the healthcare-associated infection (HAI) market. Photodisinfection provides a spectrum of antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance. The company offers solution in Steriwave Nasal Decolonization (ND) and SurgENT. Steriwave ND provides a spectrum antimicrobial providing targeted decolonization. SurgENT is a tool for cleaning and irrigating the paranasal sinuses. The intrasinus balloon design directs irrigant circumferentially around the sinus walls, maintaining debridement pressure.

OBI Intrinsic Value
4.22 GBX
Overvaluation 50%
Intrinsic Value
Price
O

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-893.8%
=
Operating Profit
-14.6m
/
Revenue
1.6m
What is the Operating Margin of Ondine Biomedical Inc?

Based on Ondine Biomedical Inc's most recent financial statements, the company has Operating Margin of -893.8%.